University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Location status: Recruiting
NCT Number: NCT06370481
This project is a pilot study to determine the feasibility and acceptability of a telemedicine intervention for substance use disorder service delivery in diverse people living with HIV in Alabama.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Birmingham, Alabama, 35294, United States
Location status: Recruiting
The contemporary drug crisis and the COVID-19 pandemic have exposed the complex syndemics of addiction and infectious diseases: rising rates of substance use disorder (SUD) have outpaced our ability to respond with a limited healthcare workforce and public health capacity. SUD is increasing in those living with and at risk for HIV, and infectious consequences of SUD, like hepatitis C, have continued, unmitigated, in rural parts of the U.S. where many states lack Medicaid expansion, syringe service programs, and public health infrastructure to respond to the drug crisis and comorbid infections. Systemic racism and regressive policies in the Deep South criminalize people who use drugs, creating additional barriers to care, HIV prevention, and addiction treatment. As a result, people who use drugs rarely receive comprehensive addiction and HIV treatment. Yet telemedicine has the potential to overcome these barriers and bypass the constraints of a brick-and-mortar clinic to link vulnerable people, including those with HIV, to care. Although telemedicine has become mainstream in recent years, few studies have evaluated telemedicine for SUD in the Deep South from the perspective of patients and providers.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Routine care administered via telemedicine
Standard of care, as received in HIV clinic settings
Time frame: 1 month, 2 months, 3 months
Follow up visit for care (either telemedicine or in person)
Contact information is provided by the study sponsor or research team.
Ellen F Eaton, MD, MSPH
CONTACT
Stephen Tyler O'Rear
CONTACT
University of Alabama at Birmingham
Other
Acronym: HEAT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07232641
Alcohol Use Disorder, Alcohol-Related Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT05934305
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Miami, Florida, United States
View Trial DetailsNCT06585631
AIDS, Acquired Immunodeficiency Syndrome
Baltimore, Maryland, United States
View Trial DetailsNCT05492825
Back Pain Lower Back Chronic, Chemically-Induced Disorders
The Bronx, New York, United States
View Trial Details